Trulieve Approved to Uplist to NYSE in Historic Milestone for U.S. Cannabis Industry

TALLAHASSEE, Fla. — June 5, 2026 — In a landmark moment for the U.S. Cannabis industry, Trulieve Cannabis Corp. announced today that it has received approval to list its subordinate voting shares on the New York Stock Exchange (NYSE), becoming one of the first major U.S. Cannabis operators to secure a listing on a premier American stock exchange. Trading is expected to begin on June 10 under the ticker symbol TRLV.

The announcement marks a significant step forward for the Cannabis sector, which has spent years seeking broader access to institutional capital markets while navigating federal regulatory restrictions. Trulieve’s NYSE approval follows a series of corporate restructuring initiatives designed to align the company with exchange requirements in the wake of federal Cannabis rescheduling and evolving regulatory guidance.

” As the first U.S. Cannabis company to list on a major U.S. exchange, we are excited for the opportunity to expand our shareholder base, increase liquidity, and raise awareness for the benefits of medical marijuana,” said CEO Kim Rivers in the company’s announcement.

(Kim Rivers)

For Trulieve, the uplisting represents more than a new trading venue. A NYSE listing is expected to improve visibility among institutional investors, increase trading liquidity, and potentially lower the company’s cost of capital. The move could also pave the way for additional Cannabis operators seeking access to major U.S. exchanges as regulatory barriers continue to soften.

The development arrives during a period of accelerating change for the Cannabis industry. Following the federal government’s move to reschedule medical marijuana to Schedule III, operators have been pursuing new opportunities related to taxation, banking, research, and capital markets access. Industry observers view Trulieve’s approval as a potential signal that major exchanges may become increasingly accessible to compliant Cannabis businesses.

Founded in Florida, Trulieve has grown into one of the largest multi-state Cannabis operators in the United States, with leading positions in key markets including Florida, Arizona, and Pennsylvania. The company has consistently generated industry-leading revenue and profitability metrics while expanding its retail footprint and product portfolio.

For investors and operators alike, the significance of the announcement extends beyond Trulieve. The successful NYSE uplisting could serve as a precedent for the broader Cannabis industry and may accelerate conversations around institutional investment, analyst coverage, and future exchange listings for other U.S. operators.

As the Cannabis sector continues its transition toward mainstream acceptance, today’s announcement may ultimately be remembered as one of the defining milestones in the industry’s evolution from a fragmented emerging market into a recognized segment of the U.S. economy.

Published by HCN